rs5705

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000537.4(REN):​c.204A>C​(p.Thr68Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 1,613,772 control chromosomes in the GnomAD database, including 16,050 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2924 hom., cov: 31)
Exomes 𝑓: 0.13 ( 13126 hom. )

Consequence

REN
NM_000537.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.627

Publications

30 publications found
Variant links:
Genes affected
REN (HGNC:9958): (renin) This gene encodes renin, an aspartic protease that is secreted by the kidneys. Renin is a part of the renin-angiotensin-aldosterone system involved in regulation of blood pressure, and electrolyte balance. This enzyme catalyzes the first step in the activation pathway of angiotensinogen by cleaving angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin I converting enzyme. This cascade can result in aldosterone release, narrowing of blood vessels, and increase in blood pressure as angiotension II is a vasoconstrictive peptide. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause hyperuricemic nephropathy familial juvenile 2, familial hyperproreninemia, and renal tubular dysgenesis. [provided by RefSeq, May 2020]
REN Gene-Disease associations (from GenCC):
  • familial juvenile hyperuricemic nephropathy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-204162058-T-G is Benign according to our data. Variant chr1-204162058-T-G is described in ClinVar as Benign. ClinVar VariationId is 256379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RENNM_000537.4 linkc.204A>C p.Thr68Thr synonymous_variant Exon 2 of 10 ENST00000272190.9 NP_000528.1 P00797-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RENENST00000272190.9 linkc.204A>C p.Thr68Thr synonymous_variant Exon 2 of 10 1 NM_000537.4 ENSP00000272190.8 P00797-1
RENENST00000638118.1 linkc.90A>C p.Thr30Thr synonymous_variant Exon 4 of 12 5 ENSP00000490307.1 A0A1B0GUZ2

Frequencies

GnomAD3 genomes
AF:
0.179
AC:
27252
AN:
151926
Hom.:
2915
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.312
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.171
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.0913
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.127
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.141
AC:
35385
AN:
251010
AF XY:
0.136
show subpopulations
Gnomad AFR exome
AF:
0.319
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.157
Gnomad EAS exome
AF:
0.0882
Gnomad FIN exome
AF:
0.112
Gnomad NFE exome
AF:
0.124
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.128
AC:
187069
AN:
1461728
Hom.:
13126
Cov.:
32
AF XY:
0.128
AC XY:
92719
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.324
AC:
10841
AN:
33476
American (AMR)
AF:
0.177
AC:
7918
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.158
AC:
4127
AN:
26136
East Asian (EAS)
AF:
0.0831
AC:
3298
AN:
39696
South Asian (SAS)
AF:
0.114
AC:
9801
AN:
86242
European-Finnish (FIN)
AF:
0.111
AC:
5912
AN:
53416
Middle Eastern (MID)
AF:
0.184
AC:
1061
AN:
5768
European-Non Finnish (NFE)
AF:
0.122
AC:
135642
AN:
1111920
Other (OTH)
AF:
0.140
AC:
8469
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
9373
18746
28118
37491
46864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4998
9996
14994
19992
24990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.180
AC:
27304
AN:
152044
Hom.:
2924
Cov.:
31
AF XY:
0.178
AC XY:
13224
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.312
AC:
12931
AN:
41444
American (AMR)
AF:
0.171
AC:
2607
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
552
AN:
3470
East Asian (EAS)
AF:
0.0913
AC:
471
AN:
5160
South Asian (SAS)
AF:
0.108
AC:
522
AN:
4816
European-Finnish (FIN)
AF:
0.102
AC:
1084
AN:
10592
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.127
AC:
8620
AN:
67972
Other (OTH)
AF:
0.160
AC:
336
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1114
2227
3341
4454
5568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
3405
Bravo
AF:
0.192
Asia WGS
AF:
0.134
AC:
468
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular dysgenesis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Familial juvenile hyperuricemic nephropathy type 2 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.2
DANN
Benign
0.23
PhyloP100
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5705; hg19: chr1-204131186; COSMIC: COSV65817452; API